TMI-1, TNF-α-Converting Enzyme Inhibitor, Protects Against Paclitaxel-Induced Neurotoxicity in the DRG Neuronal Cells In Vitro

Background: Chemotherapy-induced peripheral neuropathy (CIPN) negatively impacts cancer survivors’ quality of life and is challenging to treat with existing drugs for neuropathic pain. TNF-α is known to potentiate TRPV1 activity, which contributes to CIPN. Here, we assessed the role of TMI-1, a TNF-...

Full description

Bibliographic Details
Main Authors: Yesul Kim, Young-Hoon Jung, Seung-Bin Park, Heekee Kim, Jae-young Kwon, Hae-kyu Kim, Hyeon-Jeong Lee, Soeun Jeon, Eunsoo Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.842779/full
_version_ 1818683310298103808
author Yesul Kim
Young-Hoon Jung
Seung-Bin Park
Heekee Kim
Jae-young Kwon
Hae-kyu Kim
Hyeon-Jeong Lee
Soeun Jeon
Eunsoo Kim
Eunsoo Kim
author_facet Yesul Kim
Young-Hoon Jung
Seung-Bin Park
Heekee Kim
Jae-young Kwon
Hae-kyu Kim
Hyeon-Jeong Lee
Soeun Jeon
Eunsoo Kim
Eunsoo Kim
author_sort Yesul Kim
collection DOAJ
description Background: Chemotherapy-induced peripheral neuropathy (CIPN) negatively impacts cancer survivors’ quality of life and is challenging to treat with existing drugs for neuropathic pain. TNF-α is known to potentiate TRPV1 activity, which contributes to CIPN. Here, we assessed the role of TMI-1, a TNF-α-converting enzyme inhibitor, in paclitaxel (PAC)-induced neurotoxicity in dorsal root ganglion (DRG) cells.Materials and Methods: Immortalized DRG neuronal 50B11 cells were cultured and treated with PAC or PAC with TMI-1 following neuronal differentiation. Cell viability, analysis of neurite growth, immunofluorescence, calcium flow cytometry, western blotting, quantitative RT-PCR, and cytokine quantitation by ELISA were performed to determine the role of TMI-1 in neurotoxicity in neuronal cells.Results: PAC administration decreased the length of neurites and upregulated the expression of TRPV1 in 50B11 cells. TMI-1 administration showed a protective effect by suppressing inflammatory signaling, and secretion of TNF-α.Conclusion: TMI-1 partially protects against paclitaxel-induced neurotoxicity by reversing the upregulation of TRPV1 and decreasing levels of inflammatory cytokines, including TNF-α, IL-1β, and IL-6 in neuronal cells.
first_indexed 2024-12-17T10:32:42Z
format Article
id doaj.art-af6e7c2336ef4afd9bc054a0e3fce306
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-17T10:32:42Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-af6e7c2336ef4afd9bc054a0e3fce3062022-12-21T21:52:28ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-02-011310.3389/fphar.2022.842779842779TMI-1, TNF-α-Converting Enzyme Inhibitor, Protects Against Paclitaxel-Induced Neurotoxicity in the DRG Neuronal Cells In VitroYesul Kim0Young-Hoon Jung1Seung-Bin Park2Heekee Kim3Jae-young Kwon4Hae-kyu Kim5Hyeon-Jeong Lee6Soeun Jeon7Eunsoo Kim8Eunsoo Kim9Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Busan, South KoreaDepartment of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Busan, South KoreaDepartment of Anesthesia and Pain Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, South KoreaDepartment of Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, United StatesDepartment of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Busan, South KoreaDepartment of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Busan, South KoreaDepartment of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Busan, South KoreaDepartment of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Busan, South KoreaDepartment of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Busan, South KoreaDepartment of Anesthesia and Pain Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, South KoreaBackground: Chemotherapy-induced peripheral neuropathy (CIPN) negatively impacts cancer survivors’ quality of life and is challenging to treat with existing drugs for neuropathic pain. TNF-α is known to potentiate TRPV1 activity, which contributes to CIPN. Here, we assessed the role of TMI-1, a TNF-α-converting enzyme inhibitor, in paclitaxel (PAC)-induced neurotoxicity in dorsal root ganglion (DRG) cells.Materials and Methods: Immortalized DRG neuronal 50B11 cells were cultured and treated with PAC or PAC with TMI-1 following neuronal differentiation. Cell viability, analysis of neurite growth, immunofluorescence, calcium flow cytometry, western blotting, quantitative RT-PCR, and cytokine quantitation by ELISA were performed to determine the role of TMI-1 in neurotoxicity in neuronal cells.Results: PAC administration decreased the length of neurites and upregulated the expression of TRPV1 in 50B11 cells. TMI-1 administration showed a protective effect by suppressing inflammatory signaling, and secretion of TNF-α.Conclusion: TMI-1 partially protects against paclitaxel-induced neurotoxicity by reversing the upregulation of TRPV1 and decreasing levels of inflammatory cytokines, including TNF-α, IL-1β, and IL-6 in neuronal cells.https://www.frontiersin.org/articles/10.3389/fphar.2022.842779/fullCIPNpaclitaxeldorsal root ganglion50B11TNF-αTRPV1
spellingShingle Yesul Kim
Young-Hoon Jung
Seung-Bin Park
Heekee Kim
Jae-young Kwon
Hae-kyu Kim
Hyeon-Jeong Lee
Soeun Jeon
Eunsoo Kim
Eunsoo Kim
TMI-1, TNF-α-Converting Enzyme Inhibitor, Protects Against Paclitaxel-Induced Neurotoxicity in the DRG Neuronal Cells In Vitro
Frontiers in Pharmacology
CIPN
paclitaxel
dorsal root ganglion
50B11
TNF-α
TRPV1
title TMI-1, TNF-α-Converting Enzyme Inhibitor, Protects Against Paclitaxel-Induced Neurotoxicity in the DRG Neuronal Cells In Vitro
title_full TMI-1, TNF-α-Converting Enzyme Inhibitor, Protects Against Paclitaxel-Induced Neurotoxicity in the DRG Neuronal Cells In Vitro
title_fullStr TMI-1, TNF-α-Converting Enzyme Inhibitor, Protects Against Paclitaxel-Induced Neurotoxicity in the DRG Neuronal Cells In Vitro
title_full_unstemmed TMI-1, TNF-α-Converting Enzyme Inhibitor, Protects Against Paclitaxel-Induced Neurotoxicity in the DRG Neuronal Cells In Vitro
title_short TMI-1, TNF-α-Converting Enzyme Inhibitor, Protects Against Paclitaxel-Induced Neurotoxicity in the DRG Neuronal Cells In Vitro
title_sort tmi 1 tnf α converting enzyme inhibitor protects against paclitaxel induced neurotoxicity in the drg neuronal cells in vitro
topic CIPN
paclitaxel
dorsal root ganglion
50B11
TNF-α
TRPV1
url https://www.frontiersin.org/articles/10.3389/fphar.2022.842779/full
work_keys_str_mv AT yesulkim tmi1tnfaconvertingenzymeinhibitorprotectsagainstpaclitaxelinducedneurotoxicityinthedrgneuronalcellsinvitro
AT younghoonjung tmi1tnfaconvertingenzymeinhibitorprotectsagainstpaclitaxelinducedneurotoxicityinthedrgneuronalcellsinvitro
AT seungbinpark tmi1tnfaconvertingenzymeinhibitorprotectsagainstpaclitaxelinducedneurotoxicityinthedrgneuronalcellsinvitro
AT heekeekim tmi1tnfaconvertingenzymeinhibitorprotectsagainstpaclitaxelinducedneurotoxicityinthedrgneuronalcellsinvitro
AT jaeyoungkwon tmi1tnfaconvertingenzymeinhibitorprotectsagainstpaclitaxelinducedneurotoxicityinthedrgneuronalcellsinvitro
AT haekyukim tmi1tnfaconvertingenzymeinhibitorprotectsagainstpaclitaxelinducedneurotoxicityinthedrgneuronalcellsinvitro
AT hyeonjeonglee tmi1tnfaconvertingenzymeinhibitorprotectsagainstpaclitaxelinducedneurotoxicityinthedrgneuronalcellsinvitro
AT soeunjeon tmi1tnfaconvertingenzymeinhibitorprotectsagainstpaclitaxelinducedneurotoxicityinthedrgneuronalcellsinvitro
AT eunsookim tmi1tnfaconvertingenzymeinhibitorprotectsagainstpaclitaxelinducedneurotoxicityinthedrgneuronalcellsinvitro
AT eunsookim tmi1tnfaconvertingenzymeinhibitorprotectsagainstpaclitaxelinducedneurotoxicityinthedrgneuronalcellsinvitro